Head of Partnerships
Subsense
Head of Partnerships
Subsense
Develops noninvasive nanotech BCI devices
Salary Range: 150000 to 200000 (Currency: USD) (Pay period: per-year-salary)
Subsense is a deep-tech company developing the world’s first non-surgical, bidirectional brain-computer interface powered by plasmonic and magnetoelectric nanoparticles. Our mission is to unlock direct communication between the human brain and AI - starting with medical applications such as stroke recovery and moving toward cognitive enhancement for healthy users. Headquartered in Palo Alto, Subsense brings together leading scientists and engineers to redefine the future of human–machine interaction.
The Head of Partnerships will lead the development of high-value, non-medical strategic partnerships with leading technology companies. This role is responsible for creating and securing transformative collaborations that validate our platform and unlock long-term distribution, infrastructure, and data advantages.
We are pre-product. You will be expected to secure LOIs, pilots, and partnerships before a finished product exists.
This role requires selling vision, not product.
You'd be joining a small team developing a non-surgical, bidirectional brain-computer interface powered by plasmonic and magnetoelectric nanoparticles. You’ll help translate early research into working technology, with the opportunity to influence both the platform and how we build it.
A few things that make this different:
If you’re drawn to hard problems, hands-on discovery, and the opportunity to turn research into working technology, we’d like to hear from you.
Subsense develops nanotechnology-based noninvasive brain-computer interfaces and medical devices aimed at treating neurodegenerative diseases. Its products are designed for daily, seamless use in healthcare, combining brain signal interfaces with nanotech to aid patients and clinicians. The company works with academic experts from ETH Zurich and Stanford to guide research and development, and plans to sell or license its BCI devices in Europe and the USA. Compared with competitors, Subsense emphasizes noninvasive, nano-scale interfaces and strong collaborations to translate research into market-ready medical devices. The overarching goal is to improve quality of life for individuals with neurodegenerative conditions by delivering practical, clinician-friendly BCI solutions.
Explore more opportunities at Subsense